You just read:

China's First Fully Human, Full-length Anti-PD-L1 Monoclonal Antibody Receives Approval to Initiate Clinical Trials by the China Food and Drug Administration

News provided by

CStone Pharmaceuticals

Jul 17, 2017, 08:50 ET